J&J Open To Large-Scale Mergers; Still Prefers Centocor, Alza-Sized Deals
Executive Summary
Johnson & Johnson is open to deals larger than the $10.5 bil. Alza acquisition, CEO William Weldon said Jan. 20
You may also be interested in...
J&J Acquires Crystalline Technology Through $230 Mil. TransForm Buy
Johnson & Johnson will have access to all of TransForm Pharmaceuticals' proprietary crystalline formulation technology through its proposed $230 mil. acquisition of the privately held company
J&J Acquires Crystalline Technology Through $230 Mil. TransForm Buy
Johnson & Johnson will have access to all of TransForm Pharmaceuticals' proprietary crystalline formulation technology through its proposed $230 mil. acquisition of the privately held company
J&J Ready To Re-Balance? Guidant Deal Would Decrease Dependence On Rx
Johnson & Johnson's proposed acquisition of Guidant will help the company restore the balance in its health care portfolio